Clinical Trial Update: Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant [Phase 4]

View source ↗

Summary

Phase 4 trial in de novo kidney transplant recipients comparing Everolimus with very low tacrolimus to enteric-coated mycophenolate sodium with low tacrolimus; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Kidney Transplantation

Drugs mentioned

• Everolimus (everolimus)
• Mycophenolate sodium (mycophenolate sodium)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Ronaldo de Matos Esmeraldo, MD | Conditions: Transplantation Infection, Cytomegalovirus Infections | Phase 4 | Status: COMPLETED